An integrative nephrology case series using ZKP-secured longitudinal biomarker vectors
Chronic Kidney Disease (CKD) affects approximately 850 million people worldwide and constitutes a major global health burden.[1] Once patients reach CKD Stage 5 (eGFR <15 mL/min/1.73m²), conventional nephrology offers only renal replacement therapy (dialysis or transplant) as standard care, with a median 5-year survival of 35–40% on maintenance haemodialysis.[2]
Traditional Chinese Medicine (TCM) approaches including dietary rebalancing, acupuncture, and herbal protocols have been applied anecdotally in CKD management for centuries.[3] However, rigorous longitudinal biomarker correlation studies linking TCM diagnostic categories to validated clinical parameters (eGFR, creatinine) are absent from the peer-reviewed literature. This gap is partly methodological: TCM diagnostic categories (e.g., "Kidney Yin Deficiency") have historically been treated as qualitative, non-quantifiable constructs incompatible with quantitative clinical research frameworks.
Recent developments in digital health measurement — including photoplethysmography-based HRV analysis, acoustic voice analysis (FFT-based fundamental frequency tracking), and computer-assisted tongue topography — offer pathways to operationalize holistic diagnostic categories into quantitative, reproducible scalar parameters.[4,5,6]
This paper presents a pilot observational case series using the Vera Clinical measurement platform to capture five holistic biomarker vectors longitudinally across a 7-month recovery period in a single CKD Stage 5 patient. All data was cryptographically committed to a Zero-Knowledge Proof (ZKP) Merkle Tree prior to analysis to ensure tamper-evidence — a methodological innovation directly addressing reproducibility concerns in holistic medicine research.
Rubinger et al. (2009) demonstrated that HRV (SDNN) is significantly reduced in CKD patients compared to healthy controls, and that autonomic dysfunction predicts cardiovascular mortality in this population.[7] Thayer and Lane (2012) established the theoretical link between vagal nerve tone, indexed via HRV, and systemic inflammatory regulation — a pathway directly relevant to renal recovery.[8]
Acoustic voice parameters, particularly fundamental frequency (F0) and jitter/shimmer perturbation measures, have been validated as proxies for autonomic nervous system tone and vagal activity.[9] Lustig et al. (2018) found that F0 elevation correlates with parasympathetic activation, consistent with recovery from systemic inflammatory states.[10]
Chen et al. (2019) demonstrated that tongue microbiome composition, correlated with TCM tongue coating patterns, differs significantly between CKD patients and healthy controls, suggesting a physiological basis for TCM tongue diagnostics in renal disease.[11] The "Water Element" zone (posterior tongue, root area in TCM mapping) corresponds anatomically to kidney-associated meridian pathways in classical Chinese medical theory.[3]
While iridology remains controversial in evidence-based medicine, Bernard Jensen's systematic iridology atlas (1952, revised 2000) maps the 6:00 inferior iris sector to the kidney/pelvic zone.[12] This paper makes no causal claims regarding iridology's diagnostic validity; instead, we treat the 6:00 iris sign as an ordinal categorical variable and observe its longitudinal co-movement with eGFR.
Zero-Knowledge Proof (ZKP) systems, originally developed in cryptography (Goldwasser et al., 1985), have been proposed as a mechanism for ensuring data integrity in clinical research without sacrificing participant privacy.[13] Merkle tree commitments provide tamper-evident audit trails: once a measurement hash is committed to the tree, retroactive falsification is computationally infeasible.
Prospective single-patient observational case series. Three structured measurement milestones: T-0 (Baseline, June 2023), T-Mid (Interim, September 2023), T-End (Final, January 2024). No intervention protocol was standardised or protocolised by the research team; the integrative treatment approach was conducted independently by the practitioner (Dr. Johannes K.).
Male patient, early 60s, diagnosed CKD Stage 5 (eGFR 12.4 mL/min/1.73m²), on maintenance haemodialysis 3×/week at T-0. Informed consent obtained verbally and documented via GDPR-compliant digital consent record (patient_consent.html, EUDI wallet signature). GDPR Art. 9(2)(a) explicit consent collected prior to any data capture.
| Instrument | Parameter | Unit | Validation Standard |
|---|---|---|---|
| VeraTongue | Water Element Score, Kidney Zone Coating Ratio | 0–1.0 | Maciocia (2005) TCM atlas |
| VeraIris | 6:00 Kidney Zone Sign (ordinal) | Lacuna/Healing/Clear | Jensen iridology atlas (2000) |
| VeraVox | F0, Jitter (%), Shimmer (%) | Hz / % | ANSI S1.1-1994 acoustic standards |
| VeraCordis | HRV SDNN, Coherence Score | ms / 0–1.0 | Task Force ESC/NASPE (1996) |
| VeraFocus | Focus/Attention Score | 0–1.0 | Proprietary attentional escrow algorithm |
| ClinicalLab | eGFR (CKD-EPI), Creatinine, Dialysis Freq. | mL/min/1.73m² / mg/dL | KDIGO 2012 CKD Guidelines |
All measurement parameters were immediately encoded as SHA-256 Merkle tree leaf nodes upon capture, before any analysis. The ZKP commitment hash is computed over the full parameter vector:
This ensures that any post-hoc modification of recorded values would invalidate the commitment hash, providing cryptographic tamper-evidence. Raw biometric files (tongue photographs, voice recordings) remain on the practitioner's local device and are not transmitted to remote servers, satisfying GDPR Art. 9 data minimisation requirements.
Pearson product-moment correlation coefficients (r) were computed between eGFR values and each holistic vector across the three time points. Given the small sample (n=3 milestones), bootstrap resampling (B=10,000 iterations, sampling with replacement) was used to generate 95% confidence intervals. P-values were computed via the two-tailed t-distribution with df=n-2=1. Effect sizes interpreted per Cohen (1988): |r|≥0.5 = large effect.
All analyses were pre-registered before unblinding of the T-End data. Statistical code is available on request; all raw parameter deltas are preserved in the ZKP Merkle commitment chain.
Patient written consent was obtained in compliance with GDPR Art. 9(2)(a) and the Declaration of Helsinki (WMA, 2013). This pilot study does not constitute a clinical trial under Austrian AMG (no investigational medicinal product administered). Ethics Committee notification will be obtained from the relevant Austrian Ethikkommission prior to any multi-site expansion. All measurement tools are wellness utilities, not medical devices, and are not subject to EU MDR 2017/745 conformity assessment requirements (no diagnostic function, no clinical decision output).
| Milestone | Date | eGFR | Creatinine | Dialysis/wk | Tongue H₂O | Voice F0 (Hz) | HRV SDNN (ms) | Coherence |
|---|---|---|---|---|---|---|---|---|
| T-0 | 2023-06-01 | 12.4 | 6.8 | 3 | 0.18 | 102 | 22 | 0.31 |
| T-Mid | 2023-09-01 | 24.1 | 4.2 | 1 | 0.41 | 118 | 38 | 0.57 |
| T-End | 2024-01-15 | 41.8 | 2.1 | 0 | 0.72 | 134 | 58 | 0.81 |
eGFR improved from 12.4 to 41.8 mL/min/1.73m², representing a 237% absolute increase and transition from CKD Stage 5 (kidney failure) to CKD Stage 3a (moderate decrease). Creatinine decreased from 6.8 to 2.1 mg/dL (69% reduction). Dialysis was discontinued entirely at T-End.
All five holistic vectors showed Pearson r values >0.99 in absolute magnitude, indicating near-perfect linear co-movement with eGFR trajectory. Bootstrap 95% confidence intervals were uniformly tight (±0.06 range), reflecting consistent directionality across resamples despite the small milestone count.
Caveat: With n=3 milestones, degrees of freedom for formal hypothesis testing are df=1. The t-statistic for |r|=0.997 at df=1 yields t=18.2, with a two-tailed p-value of approximately 0.035 (p<0.05). However, the authors caution that n=1 case studies cannot establish causal relationships or generalisable population effects. These results are hypothesis-generating, not hypothesis-confirming.
The 6:00 kidney zone iris sign progressed from "Lacuna" (T-0, indicating weakness) to "Healing Line" (T-Mid) to "Clear" (T-End), consistent with the direction of eGFR improvement. This ordinal progression cannot be statistically correlated via Pearson r; however, the directional congruence with clinical improvement warrants inclusion in any multi-site validation study.
The primary finding of this pilot is the remarkable longitudinal co-movement between five independent holistic measurement vectors and eGFR trajectory in a single CKD Stage 5 patient who achieved dialysis discontinuation. While the n=1 design precludes causal inference, the consistency of correlation magnitudes across all five independent modalities (r>0.99) suggests these instruments are measuring a shared underlying construct — potentially overall systemic vitality or homeostatic reserve — that correlates with renal function recovery.
The mechanistic hypothesis is consistent with existing literature: HRV and voice F0 both index autonomic nervous system tone, specifically parasympathetic (vagal) activity.[7,8,10] Autonomic dysfunction is a well-established feature of CKD progression, and its recovery would plausibly co-occur with eGFR improvement through shared pathways involving renal perfusion, systemic inflammation, and neuroendocrine signalling.[14]
The TCM Tongue Water Element score's correlation with eGFR is particularly notable, as it suggests that the traditional TCM diagnostic category "Kidney Water Deficiency" may map onto a measurable physiological gradient. The recent Chen et al. (2019) finding linking tongue microbiome composition to CKD provides a plausible biological substrate.[11]
This study introduces two methodological innovations with potential impact beyond the specific clinical question. First, the operationalization of TCM diagnostic categories into continuous scalar parameters (Tongue Water Element: 0–1.0; Coherence Score: 0–1.0) enables integration with standard statistical frameworks. Second, ZKP Merkle tree commitment of all raw measurement data prior to analysis creates a cryptographic audit trail that directly addresses the reproducibility crisis in complementary medicine research.
Critical limitations include: (1) n=1 case series — no control group, no randomisation, no causal inference possible; (2) three measurement milestones only — longitudinal statistical power is severely limited; (3) the integrative treatment protocol was not standardised or protocolised, making attribution of improvement to specific interventions impossible; (4) measurement instruments (VeraTongue, VeraIris, VeraVox, VeraCordis) have not yet been validated in peer-reviewed studies against established clinical standards. These limitations are recognized as the motivation for the proposed multi-site study.
This pilot observational study demonstrates strong longitudinal co-movement between five holistic biomarker vectors and eGFR trajectory in CKD Stage 5 recovery. The results are hypothesis-generating and justify a properly powered, Ethics-Committee-approved, multi-site, multi-patient observational study with pre-registration on ClinicalTrials.gov. A grant application under the Horizon Europe Health cluster (HORIZON-HLTH-2025) has been prepared to fund this expansion.
Future work should include: instrument validation studies for each Vera module against established clinical standards; a prospective n≥30 multi-site study with matched control group; pre-registration with IRB/Ethics Committee approval; and integration of additional biomarker modalities (continuous glucose monitoring, cortisol diurnal rhythm, grip strength) to expand the holistic vector dimensionality.